Authors: HOOS A HEPP HH KAUL S AHLERT T BASTERT G WALLWIENER D

Citation: A. Hoos et al., TELOMERASE ACTIVITY CORRELATES WITH TUMOR AGGRESSIVENESS AND REFLECTSTHERAPY EFFECT IN BREAST-CANCER, International journal of cancer, 79(1), 1998, pp. 8-12

Authors: HOOS A HEPP HH KAUL S AHLERT T WALLWIENER D BASTERT G

Citation: A. Hoos et al., PROGNOSTIC-SIGNIFICANCE OF TELOMERASE ACTIVITY IN BREAST-CANCER, European journal of cancer, 33, 1997, pp. 894-894

Authors: AHLERT T SAUERBREI W BASTERT G RUHLAND S BARTIK B SIMIANTONAKI N SCHUMACHER J HACKER B SCHUMACHER M SCHIRRMACHER V

Citation: T. Ahlert et al., TUMOR-CELL NUMBER AND VIABILITY AS QUALITY AND EFFICACY PARAMETERS OFAUTOLOGOUS VIRUS-MODIFIED CANCER VACCINES IN PATIENTS WITH BREAST OR OVARIAN-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1354-1366

Authors: OCKERT D SCHIRRMACHER V BECK N STOELBEN E AHLERT T FLECHTENMACHER J HAGMULLER E BUCHCIK R NAGEL M SAEGER HD

Citation: D. Ockert et al., NEWCASTLE-DISEASE VIRUS-INFECTED INTACT AUTOLOGOUS TUMOR-CELL VACCINEFOR ADJUVANT ACTIVE SPECIFIC IMMUNOTHERAPY OF RESECTED COLORECTAL-CARCINOMA, Clinical cancer research, 2(1), 1996, pp. 21-28

Authors: AHLERT T

Citation: T. Ahlert, TUMOR-CELL VACCINATION AND IL-2 THERAPY, Hybridoma, 12(5), 1993, pp. 549-552